FLASCO

Reimbursement Update Permanent J code for Imfinzi

astrazeneca
  • FLASCO
  • December 14, 2018

IMFINZI is indicated for the treatment of patients with unresectable Stage III NSCLC whose disease has not progressed following concurrent platinum-based chemotherapy and radiation therapy.  The NEW Permanent J-Code is J91731 and goes into effect January 1, 2019.

Who’s Online

Profile picture of FLASCO